OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
OCX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.41%86.850.6%$503.03m
ISRGIntuitive Surgical, Inc.
1.90%517.782.4%$492.65m
TMOThermo Fisher Scientific Inc.
3.08%269.611.0%$454.54m
ABTAbbott Laboratories
1.77%78.110.8%$433.21m
BDXBecton, Dickinson and Company
2.17%237.551.1%$367.84m
ALGNAlign Technology, Inc.
-0.11%296.746.3%$348.20m
BSXBoston Scientific Corporation
4.23%36.941.1%$336.20m
SYKStryker Corporation
1.16%187.191.3%$276.11m
BAXBaxter International Inc.
-0.04%76.251.7%$241.63m
EWEdwards Lifesciences Corporation
-0.30%177.191.2%$224.13m
ABMDABIOMED, Inc.
-1.00%268.133.3%$214.45m
WATWaters Corporation
2.81%213.373.5%$149.73m
DXCMDexCom, Inc.
-0.59%118.128.4%$148.16m
ZBHZimmer Biomet Holdings, Inc.
0.20%124.701.7%$146.96m
TNDMTandem Diabetes Care, Inc.
0.52%60.164.0%$109.35m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.